(Q72546747)

English

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

scientific article published on 01 February 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

based on heuristic

inferred from title

familial combined hyperlipidemia

1 reference

based on heuristic

inferred from title

author name string

S J Bredie

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

T W de Bruin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

P N Demacker

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

J J Kastelein

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

A F Stalenhoef

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

language of work or name

0 references

publication date

1 February 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

348-353

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Combination drug therapy for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Decreased in vitro oxidizability of low-density lipoprotein in hypercholesterolaemic patients treated with 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980552-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(99)80552-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7856526%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q72546747&oldid=1933246896"